Back
Trinity Biotech PLC Vs. Perspective Therapeutics Industry Stock Comparison
Sell
23
TRIB
Trinity Biotech PLC
Last Price:
2.04
Seasonality Move:
-10.1%
Sell
33
CATX
Perspective Therapeutics
Last Price:
10.74
Seasonality Move:
5.43%
Sell
23
Trinity Biotech PLC (TRIB)
is a Sell
Is Trinity Biotech PLC a Buy, Sell or Hold?
- The current Trinity Biotech PLC [TRIB] share price is $2.03. The Score for TRIB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- TRIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $10.75. The Score for CATX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRIB Stock Price Chart
What is Trinity Biotech PLC's stock price today?
-
The Trinity Biotech PLC share price today is $2.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $10.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 45.64 | Sell |
| Chaikin Money Flow: | -39889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.05 | Sell |
| Relative Strength Index (14 RSI): | 43.39 | Sell |
| Chaikin Money Flow: | 331895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.19 - 13.23) | Sell |
| Bollinger Bands (100): | (10.08 - 15.8) | Sell |
TRIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.19 | Sell |
| 20-day SMA: | 2.37 | Sell |
| 50-day SMA: | 1.96 | Buy |
| 200-day SMA: | 2.3 | Sell |
| 8-day EMA: | 2.19 | Sell |
| 20-day EMA: | 2.22 | Sell |
| 50-day EMA: | 2.1 | Sell |
| 200-day EMA: | 2.53 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.21 | Buy |
| 20-day SMA: | 11.24 | Sell |
| 50-day SMA: | 14.18 | Sell |
| 200-day SMA: | 8.35 | Buy |
| 8-day EMA: | 10.53 | Buy |
| 20-day EMA: | 11.34 | Sell |
| 50-day EMA: | 12.62 | Sell |
| 200-day EMA: | 9.93 | Buy |
Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $0.29 per share, a decrease this year of $1.77 per share, and an increase next year of $1.13 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Trinity Biotech PLC Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||